Sequenom Grants Exclusive Promotion and Marketing Rights to Nicox for RetnaGene AMD Test in North America

Nicox (OTC: NICXF ), and Sequenom (NASDAQ: SQNM ), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an exclusive agreement in the age-related macular degeneration (AMD) field. As part of this agreement, Nicox has been granted the North American promotional rights to